CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE was reported 3029 times

CETIRIZINE HYDROCHLORIDE AND PSEUDOEPHEDRINE HYDROCHLORIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 ACRAL LENTIGINOUS MELANOMA STAGE III 1 0.2000
1 PARANASAL SINUS BENIGN NEOPLASM 2 0.2000
2 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, MIXED TYPE 2 0.0870
3 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY 55 0.0823
4 SWOLLEN JOINT COUNT 16 0.0640
5 LUPUS VULGARIS 75 0.0595
6 DEEP VEIN THROMBOSIS POSTOPERATIVE 114 0.0569
7 BLEPHARAL PAPILLOMA 1 0.0500
8 SWOLLEN JOINT COUNT INCREASED 134 0.0420
9 DISLOCATION OF VERTEBRA 85 0.0372
10 C-REACTIVE PROTEIN 34 0.0367
11 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 76 0.0366
12 TENDER JOINT COUNT 3 0.0357
13 RHEUMATOID FACTOR POSITIVE 200 0.0346
14 RHEUMATIC FEVER 152 0.0341
15 PRODUCT DIFFICULT TO REMOVE 2 0.0333
16 SERONEGATIVE ARTHRITIS 37 0.0323
17 ANTI-CYCLIC CITRULLINATED PEPTIDE ANTIBODY POSITIVE 230 0.0321
18 DUODENAL ULCER PERFORATION 224 0.0301
19 FACET JOINT SYNDROME 91 0.0279
20 RETINITIS 48 0.0278
21 X-RAY ABNORMAL 49 0.0274
22 PEMPHIGUS 330 0.0264
23 OVARIAN ATROPHY 2 0.0235
24 SUBCUTANEOUS DRUG ABSORPTION IMPAIRED 13 0.0232
25 IMPLANT SITE NECROSIS 2 0.0227
26 HAND DEFORMITY 294 0.0224
27 PERIPHERAL VENOUS DISEASE 82 0.0201
28 HELICOBACTER INFECTION 205 0.0199
29 BILIARY CANCER METASTATIC 1 0.0192
30 GRIP STRENGTH 4 0.0175
31 HYPOCHOLESTEROLAEMIA 6 0.0170
32 PERICARDITIS 278 0.0165
33 DRUG TOLERANCE DECREASED 45 0.0160
34 BONE EROSION 54 0.0153
35 APPLICATION SITE CELLULITIS 1 0.0149
36 MUSCLE INJURY 123 0.0148
37 ACQUIRED PORPHYRIA 1 0.0141
38 SYNOVITIS 251 0.0139
39 GLOSSODYNIA 299 0.0133
40 SLEEP DISORDER DUE TO GENERAL MEDICAL CONDITION, INSOMNIA TYPE 86 0.0132
41 FOLLICULITIS 138 0.0131
42 BREAST CANCER STAGE III 82 0.0126
43 C-REACTIVE PROTEIN ABNORMAL 73 0.0114
44 AUTOIMMUNE DISORDER 108 0.0111
45 LIVE BIRTH 91 0.0109
46 WOUND 289 0.0103
47 LYMPH NODE CALCIFICATION 2 0.0103
48 SYSTEMIC LUPUS ERYTHEMATOSUS 320 0.0090
49 PRODUCT PACKAGE ASSOCIATED INJURY 20 0.0090
50 PRODUCT CLOSURE REMOVAL DIFFICULT 9 0.0088
51 WOUND INFECTION 96 0.0088
52 MECONIUM IN AMNIOTIC FLUID 3 0.0085
53 HYPERCHOLESTEROLAEMIA 82 0.0085
54 EXOSTOSIS 77 0.0084
55 GRIP STRENGTH DECREASED 74 0.0084
56 ANTI-THYROID ANTIBODY INCREASED 1 0.0079
57 LIP DRY 71 0.0078
58 WRONG PATIENT RECEIVED MEDICATION 21 0.0077
59 SPONDYLITIS 27 0.0074
60 OVERLAP SYNDROME 5 0.0071
61 CONTRAINDICATED PRODUCT ADMINISTERED 214 0.0071
62 BURSITIS 85 0.0070
63 BLEPHAROSPASM 44 0.0070
64 PORPHYRIA ACUTE 10 0.0070
65 JOINT RANGE OF MOTION DECREASED 92 0.0069
66 WALKING AID USER 45 0.0068
67 INFUSION SITE REACTION 20 0.0067
68 HYPNAGOGIC HALLUCINATION 2 0.0066
69 PRESCRIBED OVERDOSE 127 0.0066
70 ANAL DISCOMFORT 1 0.0065
71 LIVER INJURY 159 0.0065
72 FIBROMYALGIA 152 0.0062
73 PULMONARY ARTERY DILATATION 2 0.0058
74 JOINT DESTRUCTION 9 0.0058
75 DEATH NEONATAL 8 0.0057
76 ARTERIOVENOUS FISTULA OCCLUSION 1 0.0057
77 BACTERIAL COLITIS 1 0.0056
78 LOWER LIMB FRACTURE 105 0.0055
79 IRRITABLE BOWEL SYNDROME 117 0.0055
80 TYPE 2 DIABETES MELLITUS 179 0.0053
81 HIP ARTHROPLASTY 80 0.0052
82 RED BLOOD CELL SEDIMENTATION RATE INCREASED 57 0.0051
83 SCIATICA 82 0.0051
84 BREAST CANCER STAGE II 41 0.0049
85 ARTHROPATHY 272 0.0049
86 LUPUS-LIKE SYNDROME 44 0.0048
87 EYE INJURY 14 0.0046
88 SINUS RHYTHM 2 0.0046
89 PEAK EXPIRATORY FLOW RATE DECREASED 2 0.0045
90 CERVICITIS 2 0.0045
91 PRESCRIBED UNDERDOSE 87 0.0044
92 DRUG TOLERANCE 22 0.0043
93 FOOT DEFORMITY 48 0.0043
94 DISCOMFORT 264 0.0043
95 PULMONARY FIBROSIS 82 0.0043
96 METAPLASIA 2 0.0042
97 PSORIATIC ARTHROPATHY 168 0.0041
98 JOINT DISLOCATION 43 0.0041
99 VOCAL CORD DYSFUNCTION 2 0.0041
100 AMPHETAMINES POSITIVE 3 0.0040
101 ADENOTONSILLECTOMY 1 0.0040
102 INFUSION RELATED REACTION 263 0.0040
103 OBESITY 63 0.0040
104 KNEE ARTHROPLASTY 83 0.0039
105 THERAPEUTIC PRODUCT EFFECT DECREASED 176 0.0039
106 ULCER HAEMORRHAGE 26 0.0038
107 IMPAIRED HEALING 126 0.0038
108 ONYCHOMADESIS 16 0.0038
109 GAIT INABILITY 120 0.0036
110 BLOOD CHOLESTEROL INCREASED 167 0.0036
111 ADMINISTRATION SITE ERYTHEMA 1 0.0035
112 SINUS POLYP 2 0.0035
113 SPINAL FUSION SURGERY 14 0.0034
114 HEPATIC ENZYME INCREASED 234 0.0034
115 MATERNAL EXPOSURE DURING PREGNANCY 304 0.0034
116 THERAPEUTIC RESPONSE UNEXPECTED 145 0.0032
117 ANGIOIMMUNOBLASTIC T-CELL LYMPHOMA 1 0.0032
118 PERIORAL DERMATITIS 2 0.0031
119 SWELLING 294 0.0031
120 BLISTER 173 0.0031
121 ADMINISTRATION SITE SWELLING 1 0.0031
122 MITE ALLERGY 2 0.0031
123 PRODUCT PACKAGING ISSUE 29 0.0030
124 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 52 0.0030
125 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
126 BENIGN NEOPLASM OF SKIN 1 0.0030
127 MATERNAL EXPOSURE TIMING UNSPECIFIED 11 0.0029
128 HEPATIC CIRRHOSIS 55 0.0029
129 RHEUMATOID ARTHRITIS 331 0.0029
130 PUSTULAR PSORIASIS 10 0.0029
131 BASAL GANGLIA INFARCTION 1 0.0029
132 ATHEROSCLEROSIS 1 0.0029
133 PRODUCT BLISTER PACKAGING ISSUE 3 0.0029
134 ASTHMA EXERCISE INDUCED 1 0.0029
135 INFUSION SITE DISCHARGE 5 0.0028
136 BRONCHIAL OBSTRUCTION 4 0.0028
137 DRUG INTOLERANCE 268 0.0028
138 FIBROCYSTIC BREAST DISEASE 2 0.0027
139 PRODUCT LOT NUMBER ISSUE 6 0.0027
140 PRODUCT PACKAGING DIFFICULT TO OPEN 7 0.0027
141 NASAL SEPTUM DEVIATION 5 0.0026
142 OSTEOARTHRITIS 108 0.0025
143 NIGHT SWEATS 81 0.0025
144 TREATMENT FAILURE 208 0.0025
145 EXCESSIVE GRANULATION TISSUE 2 0.0025
146 HAND-FOOT-AND-MOUTH DISEASE 2 0.0024
147 CSF PROTEIN INCREASED 2 0.0024
148 COVID-19 IMMUNISATION 2 0.0024
149 OEDEMA 130 0.0024
150 PRODUCT USED FOR UNKNOWN INDICATION 3 0.0024
151 EAR INFECTION 63 0.0024
152 EAR PAIN 46 0.0024
153 JOINT STIFFNESS 62 0.0024
154 DELIRIUM 82 0.0024
155 ROAD TRAFFIC ACCIDENT 98 0.0023
156 ALLERGIC SINUSITIS 2 0.0023
157 INJURY 164 0.0023
158 LOWER RESPIRATORY TRACT INFECTION 104 0.0023
159 WHEEZING 135 0.0023
160 DISABILITY 44 0.0022
161 RIGHT VENTRICULAR HYPERTROPHY 2 0.0022
162 ALLERGY TO ARTHROPOD STING 1 0.0022
163 ALLERGY TO PLANTS 1 0.0022
164 NAIL DISORDER 19 0.0022
165 ABULIA 2 0.0022
166 STOMATITIS 130 0.0021
167 PRODUCT EXPIRATION DATE ISSUE 3 0.0021
168 THERAPEUTIC RESPONSE INCREASED 2 0.0021
169 EPILEPSY 65 0.0021
170 JOINT SWELLING 256 0.0021
171 WEIGHT ABNORMAL 5 0.0021
172 ABDOMINAL DISCOMFORT 342 0.0020
173 THERAPY NON-RESPONDER 91 0.0020
174 MOBILITY DECREASED 141 0.0020
175 MUSCULOSKELETAL STIFFNESS 171 0.0019
176 ACCIDENT AT HOME 1 0.0019
177 PRE-EXISTING CONDITION IMPROVED 12 0.0019
178 INTENTIONAL PRODUCT USE ISSUE 166 0.0019
179 ALLERGY TO ANIMAL 2 0.0019
180 RASH VESICULAR 9 0.0019
181 PREGNANCY 37 0.0018
182 C-REACTIVE PROTEIN INCREASED 66 0.0018
183 NEPHROSCLEROSIS 2 0.0018
184 MULTIPLE ALLERGIES 14 0.0018
185 EXPOSURE VIA BREAST MILK 7 0.0018
186 RADIATION SKIN INJURY 2 0.0017
187 TASTE DISORDER 35 0.0017
188 POLYARTHRITIS 9 0.0017
189 ALOPECIA 335 0.0017
190 LIVER FUNCTION TEST INCREASED 36 0.0017
191 JOINT ARTHROPLASTY 3 0.0017
192 EMBOLISM ARTERIAL 2 0.0017
193 SINUSITIS 169 0.0016
194 DRUG SCREEN POSITIVE 13 0.0016
195 PRODUCT USE ISSUE 307 0.0016
196 MUSCULOSKELETAL PAIN 85 0.0016
197 LIVER DISORDER 71 0.0016
198 NASAL PRURITUS 2 0.0016
199 LUNG DISORDER 78 0.0016
200 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 27 0.0016
201 ANAL INFLAMMATION 1 0.0016
202 BACK INJURY 17 0.0016
203 CONGENITAL ANOMALY 12 0.0015
204 EXPOSURE DURING PREGNANCY 96 0.0015
205 INFLAMMATION 79 0.0015
206 DRY MOUTH 124 0.0015
207 HYPERSENSITIVITY 282 0.0015
208 SLEEP DISORDER 107 0.0015
209 REBOUND ATOPIC DERMATITIS 3 0.0015
210 PRODUCT LABEL ISSUE 10 0.0015
211 NORMAL NEWBORN 8 0.0015
212 UPPER RESPIRATORY TRACT INFECTION 68 0.0015
213 CARBON DIOXIDE INCREASED 2 0.0015
214 IMMUNOGLOBULINS DECREASED 2 0.0015
215 NASAL DRYNESS 9 0.0014
216 PHARYNGEAL ERYTHEMA 3 0.0014
217 PELVIC VENOUS THROMBOSIS 2 0.0014
218 BITE 1 0.0014
219 GENERAL PHYSICAL HEALTH DETERIORATION 160 0.0014
220 ALANINE AMINOTRANSFERASE DECREASED 1 0.0014
221 MIGRAINE 131 0.0014
222 OBSTRUCTIVE SLEEP APNOEA SYNDROME 2 0.0014
223 DRUG-INDUCED LIVER INJURY 43 0.0014
224 ATROPHIC VULVOVAGINITIS 1 0.0014
225 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 65 0.0014
226 ASTHMA 152 0.0013
227 GASTROINTESTINAL DISORDER 120 0.0013
228 RESPIRATORY DISORDER 40 0.0013
229 CHRONIC SINUSITIS 5 0.0013
230 MUSCLE SPASTICITY 16 0.0013
231 ORAL MUCOSAL ERYTHEMA 2 0.0013
232 INCORRECT DRUG ADMINISTRATION DURATION 36 0.0013
233 DYSPEPSIA 125 0.0013
234 CYSTITIS INTERSTITIAL 2 0.0012
235 OSTEOPOROSIS 51 0.0012
236 ILL-DEFINED DISORDER 75 0.0012
237 OPTIC ATROPHY 2 0.0012
238 INTESTINAL POLYP 2 0.0012
239 INFUSION SITE HAEMORRHAGE 4 0.0012
240 AMNESIA 78 0.0012
241 EYELID IRRITATION 3 0.0012
242 BILIARY DYSKINESIA 2 0.0012
243 INCREASED BRONCHIAL SECRETION 3 0.0012
244 LACTOSE INTOLERANCE 3 0.0012
245 CONTUSION 112 0.0012
246 HYPOAESTHESIA 174 0.0012
247 ADVERSE EVENT 107 0.0012
248 HYPERTRANSAMINASAEMIA 8 0.0011
249 VERTIGO POSITIONAL 2 0.0011
250 PRODUCT USE IN UNAPPROVED INDICATION 280 0.0011
251 SKIN WEEPING 4 0.0011
252 MYOSITIS 10 0.0011
253 MONOCYTE COUNT INCREASED 4 0.0011
254 URTICARIA 182 0.0011
255 BIOPSY 1 0.0011
256 DRUG ADMINISTRATION ERROR 33 0.0011
257 HYPERTENSIVE HEART DISEASE 2 0.0011
258 POOR QUALITY SLEEP 23 0.0011
259 SOMNAMBULISM 7 0.0011
260 PARANASAL SINUS DISCOMFORT 4 0.0011
261 PANCREATIC CARCINOMA METASTATIC 3 0.0011
262 HYPERCOAGULATION 2 0.0010
263 PARANASAL SINUS HYPERSECRETION 4 0.0010
264 ANTINUCLEAR ANTIBODY INCREASED 1 0.0010
265 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 74 0.0010
266 BLADDER CATHETERISATION 1 0.0010
267 THERAPEUTIC PRODUCT EFFECT VARIABLE 4 0.0010
268 ANTIBIOTIC THERAPY 1 0.0010
269 ENERGY INCREASED 6 0.0010
270 INFECTION 147 0.0010
271 ADVERSE DRUG REACTION 91 0.0010
272 REBOUND ACID HYPERSECRETION 3 0.0010
273 THERAPEUTIC RESPONSE DECREASED 60 0.0010
274 AUTONOMIC NEUROPATHY 1 0.0010
275 HYPERPARATHYROIDISM 2 0.0010
276 NASOPHARYNGITIS 177 0.0010
277 BLOOD BLISTER 3 0.0010
278 FOETAL DISTRESS SYNDROME 2 0.0009
279 PERIPHERAL SWELLING 144 0.0009
280 GENERAL SYMPTOM 7 0.0009
281 BRONCHITIS 69 0.0009
282 JAW FRACTURE 2 0.0009
283 BLADDER DILATATION 1 0.0009
284 ACARODERMATITIS 1 0.0009
285 ONYCHOMYCOSIS 4 0.0009
286 SINUS DISORDER 18 0.0009
287 MIDDLE EAR EFFUSION 2 0.0009
288 ADRENAL INSUFFICIENCY 11 0.0009
289 FEELING JITTERY 17 0.0009
290 GASTRIC POLYPS 2 0.0009
291 ARTERIAL HAEMORRHAGE 1 0.0009
292 IMPLANT SITE INFECTION 2 0.0009
293 SINUS PAIN 2 0.0009
294 ALLODYNIA 1 0.0009
295 MUSCLE CONTRACTIONS INVOLUNTARY 3 0.0009
296 HANGOVER 3 0.0009
297 SEASONAL ALLERGY 12 0.0008
298 BILE DUCT CANCER 1 0.0008
299 URINE FLOW DECREASED 2 0.0008
300 RASH 362 0.0008
301 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 59 0.0008
302 STARING 2 0.0008
303 BREATH ODOUR 2 0.0008
304 IMMUNODEFICIENCY 12 0.0008
305 HYPERPARATHYROIDISM SECONDARY 2 0.0008
306 HYPERTENSION 169 0.0008
307 MUSCULAR WEAKNESS 90 0.0008
308 ENDODONTIC PROCEDURE 2 0.0008
309 EXPIRED PRODUCT ADMINISTERED 26 0.0008
310 ABDOMINAL PAIN UPPER 160 0.0008
311 MENOPAUSE 2 0.0008
312 ANAEMIA POSTOPERATIVE 1 0.0008
313 NASAL DISORDER 2 0.0008
314 LOW TURNOVER OSTEOPATHY 3 0.0008
315 ABDOMINAL MASS 2 0.0007
316 CONDITION AGGRAVATED 227 0.0007
317 WEIGHT BEARING DIFFICULTY 2 0.0007
318 STRESS FRACTURE 4 0.0007
319 DERMATITIS ATOPIC 39 0.0007
320 ORAL FUNGAL INFECTION 2 0.0007
321 ONYCHOCLASIS 5 0.0007
322 CONFUSIONAL STATE 117 0.0007
323 DRUG SCREEN FALSE POSITIVE 2 0.0007
324 CYSTIC FIBROSIS 4 0.0007
325 OEDEMA PERIPHERAL 88 0.0007
326 THERAPEUTIC RESPONSE DELAYED 2 0.0007
327 COELIAC DISEASE 7 0.0007
328 CHEST PAIN 131 0.0007
329 FORCED EXPIRATORY VOLUME DECREASED 2 0.0007
330 INCORRECT DRUG ADMINISTRATION RATE 3 0.0007
331 SHOULDER OPERATION 3 0.0007
332 UPPER RESPIRATORY TRACT CONGESTION 2 0.0007
333 DYSPNOEA AT REST 2 0.0007
334 ARTHRITIS 54 0.0007
335 GINGIVAL SWELLING 3 0.0007
336 MEMORY IMPAIRMENT 93 0.0007
337 BACK DISORDER 11 0.0007
338 RHINITIS ALLERGIC 3 0.0007
339 SINUS HEADACHE 4 0.0007
340 AXILLARY PAIN 1 0.0007
341 COLITIS ULCERATIVE 30 0.0007
342 GASTROOESOPHAGEAL REFLUX DISEASE 54 0.0007
343 PAIN 409 0.0007
344 SUSPECTED OFF LABEL USE 3 0.0007
345 CENTRAL VENOUS CATHETERISATION 2 0.0007
346 DECREASED APPETITE 153 0.0007
347 WEIGHT INCREASED 146 0.0007
348 PHARYNGITIS STREPTOCOCCAL 7 0.0006
349 BACTERIAL VAGINOSIS 1 0.0006
350 SKIN TIGHTNESS 3 0.0006
351 INSOMNIA 169 0.0006
352 INFUSION SITE PRURITUS 2 0.0006
353 SPINAL DISORDER 6 0.0006
354 RESPIRATORY TRACT CONGESTION 10 0.0006
355 SLEEP APNOEA SYNDROME 12 0.0006
356 GAIT DISTURBANCE 119 0.0006
357 SKIN EROSION 2 0.0006
358 RHINITIS 5 0.0006
359 CARDIAC FLUTTER 4 0.0006
360 DIZZINESS POSTURAL 6 0.0006
361 PARAESTHESIA 97 0.0006
362 PHARYNGEAL SWELLING 6 0.0006
363 ECZEMA 32 0.0006
364 MEDICATION ERROR 33 0.0006
365 VISUAL IMPAIRMENT 73 0.0006
366 HEPATIC CYST 2 0.0006
367 INITIAL INSOMNIA 6 0.0006
368 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 32 0.0006
369 REGURGITATION 2 0.0006
370 ACUTE SINUSITIS 1 0.0006
371 SNEEZING 13 0.0006
372 GRANULOMA 2 0.0006
373 TACHYPHRENIA 2 0.0006
374 ANXIETY 163 0.0006
375 THROMBOPHLEBITIS 2 0.0006
376 SCRATCH 6 0.0006
377 HAND FRACTURE 4 0.0006
378 SKIN FISSURES 11 0.0006
379 PRURITUS 214 0.0006
380 BONE LESION 2 0.0006
381 ARTHRALGIA 229 0.0006
382 WITHDRAWAL SYNDROME 23 0.0005
383 NONSPECIFIC REACTION 3 0.0005
384 SKIN HAEMORRHAGE 8 0.0005
385 TENDON INJURY 2 0.0005
386 NEURODERMATITIS 2 0.0005
387 BLOOD CHOLESTEROL DECREASED 1 0.0005
388 RETINOPATHY 2 0.0005
389 FATIGUE 417 0.0005
390 BLADDER SPASM 1 0.0005
391 PERIORBITAL SWELLING 3 0.0005
392 PAROSMIA 4 0.0005
393 FACE INJURY 2 0.0005
394 ARTERIAL DISORDER 1 0.0005
395 COMMUNICATION DISORDER 2 0.0005
396 ADRENAL DISORDER 1 0.0005
397 HYPERVENTILATION 3 0.0005
398 PRODUCT LABEL CONFUSION 3 0.0005
399 RHINOVIRUS INFECTION 2 0.0005
400 VITAMIN D DEFICIENCY 5 0.0005
401 VIRAL INFECTION 17 0.0005
402 BRAIN FOG 8 0.0005
403 URINE ODOUR ABNORMAL 3 0.0005
404 DEPRESSION 116 0.0005
405 PRODUCT ADMINISTRATION INTERRUPTED 4 0.0005
406 DECREASED INTEREST 3 0.0005
407 MUSCLE SPASMS 93 0.0005
408 EYE PRURITUS 17 0.0005
409 ANORECTAL DISORDER 1 0.0005
410 CANDIDIASIS 2 0.0005
411 MATERNAL EXPOSURE DURING BREAST FEEDING 2 0.0005
412 TOOTH ABSCESS 5 0.0005
413 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
414 CONJUNCTIVITIS 9 0.0005
415 PHARYNGITIS 6 0.0005
416 ANOSMIA 7 0.0005
417 PSYCHOMOTOR HYPERACTIVITY 8 0.0005
418 PRODUCTIVE COUGH 23 0.0005
419 RED CELL DISTRIBUTION WIDTH INCREASED 2 0.0005
420 TENDERNESS 5 0.0005
421 WEIGHT FLUCTUATION 5 0.0005
422 ATTENTION DEFICIT HYPERACTIVITY DISORDER 2 0.0005
423 INTERVERTEBRAL DISC DISORDER 2 0.0005
424 VITAMIN D DECREASED 4 0.0005
425 PROCTALGIA 3 0.0005
426 HEREDITARY ANGIOEDEMA 5 0.0005
427 LACRIMATION INCREASED 14 0.0005
428 MUSCLE STRAIN 4 0.0005
429 RESPIRATORY TRACT INFECTION 12 0.0005
430 BONE CANCER 2 0.0005
431 DIVERTICULUM INTESTINAL 2 0.0005
432 PULMONARY FUNCTION TEST DECREASED 2 0.0005
433 BIPOLAR I DISORDER 1 0.0005
434 SPINAL OSTEOARTHRITIS 4 0.0005
435 PAIN IN EXTREMITY 133 0.0005
436 SKIN MASS 3 0.0004
437 WRONG DRUG ADMINISTERED 4 0.0004
438 TERMINAL STATE 3 0.0004
439 SOMNOLENCE 90 0.0004
440 OFF LABEL USE 390 0.0004
441 URINARY TRACT DISORDER 2 0.0004
442 THROAT TIGHTNESS 12 0.0004
443 DRY EYE 22 0.0004
444 MATERNAL EXPOSURE BEFORE PREGNANCY 3 0.0004
445 TREATMENT NONCOMPLIANCE 24 0.0004
446 DIZZINESS 216 0.0004
447 LOCALISED OEDEMA 2 0.0004
448 NEPHROGENIC ANAEMIA 2 0.0004
449 FEELING OF DESPAIR 2 0.0004
450 DRUG INEFFECTIVE 565 0.0004
451 APPENDICITIS 4 0.0004
452 PYREXIA 148 0.0004
453 TACHYCARDIA 38 0.0004
454 VAGINAL INFECTION 2 0.0004
455 SKIN ABRASION 2 0.0004
456 SARCOIDOSIS 2 0.0004
457 PRE-ECLAMPSIA 2 0.0004
458 MEDICATION RESIDUE PRESENT 2 0.0004
459 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 3 0.0004
460 VOMITING 195 0.0004
461 HEADACHE 259 0.0004
462 FINGER DEFORMITY 2 0.0004
463 NOCTURIA 5 0.0004
464 UTERINE LEIOMYOMA 3 0.0004
465 HORMONE LEVEL ABNORMAL 2 0.0004
466 ORAL DISORDER 3 0.0004
467 INFLAMMATORY BOWEL DISEASE 4 0.0004
468 FREQUENT BOWEL MOVEMENTS 11 0.0004
469 PSORIASIS 53 0.0004
470 HYPERVOLAEMIA 2 0.0004
471 FEELING DRUNK 3 0.0004
472 RHINORRHOEA 26 0.0004
473 PNEUMONIA 130 0.0004
474 UNDERDOSE 29 0.0004
475 RECTAL HAEMORRHAGE 17 0.0004
476 ABDOMINAL PAIN 92 0.0004
477 PATHOLOGICAL FRACTURE 2 0.0004
478 INSURANCE ISSUE 6 0.0004
479 NASAL CONGESTION 23 0.0004
480 DRY SKIN 52 0.0004
481 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 70 0.0004
482 ILLNESS 40 0.0004
483 GASTROENTERITIS VIRAL 7 0.0004
484 CONCUSSION 3 0.0004
485 PALPITATIONS 45 0.0004
486 APLASTIC ANAEMIA 2 0.0004
487 SENSITIVITY TO WEATHER CHANGE 2 0.0004
488 ANKYLOSING SPONDYLITIS 5 0.0004
489 NECK PAIN 21 0.0004
490 ANIMAL BITE 1 0.0004
491 FEELING HOT 23 0.0004
492 DYSPNOEA 212 0.0004
493 FOOD POISONING 2 0.0004
494 ANAESTHETIC COMPLICATION 1 0.0004
495 SINUS CONGESTION 5 0.0004
496 WEIGHT DECREASED 103 0.0004
497 INFECTIVE PULMONARY EXACERBATION OF CYSTIC FIBROSIS 2 0.0004
498 HYDROCEPHALUS 2 0.0004
499 ASPIRATION 4 0.0004
500 TOOTH FRACTURE 4 0.0004
501 CHOKING SENSATION 2 0.0004
502 INJECTION SITE INJURY 2 0.0004
503 OCULAR HYPERAEMIA 17 0.0004
504 MALAISE 157 0.0004
505 ANAL HAEMORRHAGE 1 0.0004
506 SKIN INFECTION 4 0.0004
507 INFUSION SITE ERYTHEMA 3 0.0004
508 SKIN EXFOLIATION 30 0.0004
509 SKIN REACTION 5 0.0004
510 CARDIAC VALVE DISEASE 2 0.0003
511 SPINAL FRACTURE 7 0.0003
512 IMPAIRED QUALITY OF LIFE 5 0.0003
513 EXPOSURE VIA SKIN CONTACT 9 0.0003
514 ASTHENIA 130 0.0003
515 COVID-19 PNEUMONIA 4 0.0003
516 ODYNOPHAGIA 2 0.0003
517 ATYPICAL PNEUMONIA 1 0.0003
518 SYMPTOM RECURRENCE 2 0.0003
519 WRIST FRACTURE 4 0.0003
520 RESTLESS LEGS SYNDROME 6 0.0003
521 INCREASED TENDENCY TO BRUISE 3 0.0003
522 MENISCUS INJURY 2 0.0003
523 INTERVERTEBRAL DISC DEGENERATION 3 0.0003
524 INCORRECT DOSE ADMINISTERED 74 0.0003
525 PRODUCT DISTRIBUTION ISSUE 3 0.0003
526 TENDONITIS 5 0.0003
527 SCOLIOSIS 2 0.0003
528 INFUSION SITE EXTRAVASATION 2 0.0003
529 MIDDLE INSOMNIA 6 0.0003
530 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
531 FLANK PAIN 3 0.0003
532 PHOTOPHOBIA 6 0.0003
533 INFUSION SITE SWELLING 2 0.0003
534 DIARRHOEA 205 0.0003
535 BLADDER PAIN 1 0.0003
536 TOOTH DISORDER 7 0.0003
537 THROAT IRRITATION 14 0.0003
538 POOR QUALITY DRUG ADMINISTERED 2 0.0003
539 MUSCLE TIGHTNESS 5 0.0003
540 ANTINUCLEAR ANTIBODY POSITIVE 1 0.0003
541 DEEP VEIN THROMBOSIS 20 0.0003
542 KNEE OPERATION 3 0.0003
543 TOOTH INFECTION 4 0.0003
544 HYPOKALAEMIA 14 0.0003
545 PRODUCT QUALITY ISSUE 41 0.0003
546 APPETITE DISORDER 2 0.0003
547 CHOLECYSTITIS CHRONIC 2 0.0003
548 QUALITY OF LIFE DECREASED 4 0.0003
549 BREAST MASS 2 0.0003
550 FULL BLOOD COUNT DECREASED 6 0.0003
551 EXTRA DOSE ADMINISTERED 12 0.0003
552 WRONG PRODUCT ADMINISTERED 2 0.0003
553 FLUID RETENTION 15 0.0003
554 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 2 0.0003
555 ABNORMAL LOSS OF WEIGHT 2 0.0003
556 EUPHORIC MOOD 3 0.0003
557 EAR DISCOMFORT 3 0.0003
558 ABNORMAL DREAMS 8 0.0003
559 HAIR GROWTH ABNORMAL 2 0.0003
560 WHITE BLOOD CELL COUNT INCREASED 11 0.0003
561 APHONIA 4 0.0003
562 NAUSEA 226 0.0003
563 RIGHT VENTRICULAR FAILURE 2 0.0003
564 INJECTION SITE URTICARIA 7 0.0003
565 CLOSTRIDIUM DIFFICILE COLITIS 3 0.0003
566 PRODUCT DOSE OMISSION IN ERROR 8 0.0003
567 RETINAL HAEMORRHAGE 2 0.0003
568 APPENDICECTOMY 1 0.0003
569 GALLBLADDER DISORDER 5 0.0003
570 VERTIGO 17 0.0003
571 APPARENT DEATH 1 0.0003
572 TONGUE DISORDER 2 0.0003
573 DRUG EFFECT INCOMPLETE 10 0.0003
574 OESOPHAGITIS 3 0.0003
575 BONE DISORDER 5 0.0003
576 LIQUID PRODUCT PHYSICAL ISSUE 2 0.0003
577 MAJOR DEPRESSION 2 0.0003
578 CHEST DISCOMFORT 28 0.0003
579 SENSITIVE SKIN 2 0.0003
580 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
581 THINKING ABNORMAL 5 0.0003
582 SUNBURN 2 0.0003
583 OCULAR DISCOMFORT 3 0.0003
584 EYE INFECTION 3 0.0003
585 REBOUND EFFECT 3 0.0003
586 PANCREATITIS 14 0.0003
587 TENDON PAIN 2 0.0003
588 IMPAIRED DRIVING ABILITY 3 0.0003
589 FOOT FRACTURE 5 0.0003
590 DERMATITIS CONTACT 3 0.0003
591 HEART RATE INCREASED 26 0.0003
592 RENAL FAILURE CHRONIC 2 0.0003
593 FOOD ALLERGY 2 0.0003
594 RASH PRURITIC 14 0.0003
595 CHOKING 5 0.0003
596 ORAL HERPES 5 0.0003
597 MENORRHAGIA 5 0.0003
598 PRODUCT USE COMPLAINT 4 0.0003
599 COUGH 71 0.0003
600 BLOOD ALBUMIN DECREASED 2 0.0003
601 RENAL CYST 2 0.0003
602 TRICUSPID VALVE INCOMPETENCE 2 0.0003
603 ACCIDENT 3 0.0003
604 UPPER LIMB FRACTURE 5 0.0003
605 FEELING ABNORMAL 60 0.0003
606 BLOOD PRESSURE FLUCTUATION 6 0.0002
607 TRANSPLANT REJECTION 2 0.0002
608 BLEPHARITIS 1 0.0002
609 OBSESSIVE-COMPULSIVE DISORDER 2 0.0002
610 PRODUCT ADMINISTRATION ERROR 5 0.0002
611 NEURALGIA 6 0.0002
612 POST PROCEDURAL INFECTION 2 0.0002
613 RIB FRACTURE 5 0.0002
614 TENDON RUPTURE 3 0.0002
615 SPINAL COMPRESSION FRACTURE 2 0.0002
616 ACCIDENTAL EXPOSURE 1 0.0002
617 LEUKOPENIA 12 0.0002
618 INTENTIONAL PRODUCT MISUSE 21 0.0002
619 DERMATITIS 5 0.0002
620 DRUG USE DISORDER 2 0.0002
621 SENSATION OF FOREIGN BODY 2 0.0002
622 ABNORMAL SENSATION IN EYE 1 0.0002
623 MUSCULOSKELETAL DISCOMFORT 4 0.0002
624 HIATUS HERNIA 3 0.0002
625 DIPLOPIA 6 0.0002
626 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
627 RASH MACULAR 8 0.0002
628 URINE OUTPUT DECREASED 2 0.0002
629 EOSINOPHILIA 4 0.0002
630 INJECTION SITE RASH 7 0.0002
631 GROIN PAIN 2 0.0002
632 OROPHARYNGEAL PAIN 21 0.0002
633 LUNG INFILTRATION 2 0.0002
634 CHRONIC KIDNEY DISEASE 17 0.0002
635 ORAL PAIN 5 0.0002
636 SURGERY 13 0.0002
637 OROPHARYNGEAL DISCOMFORT 2 0.0002
638 OSTEOMYELITIS 4 0.0002
639 OPTIC NEURITIS 2 0.0002
640 IMPAIRED GASTRIC EMPTYING 3 0.0002
641 ACCIDENTAL OVERDOSE 8 0.0002
642 RESTLESSNESS 8 0.0002
643 BLOOD THYROID STIMULATING HORMONE INCREASED 2 0.0002
644 BREAST CANCER STAGE I 2 0.0002
645 POLLAKIURIA 9 0.0002
646 HOSPITALISATION 33 0.0002
647 EPISTAXIS 16 0.0002
648 EYE PAIN 12 0.0002
649 LACERATION 2 0.0002
650 SQUAMOUS CELL CARCINOMA 2 0.0002
651 THERAPEUTIC RESPONSE SHORTENED 7 0.0002
652 SPUTUM DISCOLOURED 2 0.0002
653 BRONCHOSPASM 3 0.0002
654 RED BLOOD CELL COUNT DECREASED 6 0.0002
655 PARAESTHESIA ORAL 3 0.0002
656 ACUTE RESPIRATORY FAILURE 4 0.0002
657 HYPERTHYROIDISM 3 0.0002
658 ATELECTASIS 2 0.0002
659 ACCIDENTAL EXPOSURE TO PRODUCT 21 0.0002
660 THERAPY CHANGE 2 0.0002
661 LABORATORY TEST ABNORMAL 6 0.0002
662 URINARY INCONTINENCE 6 0.0002
663 LIGAMENT SPRAIN 2 0.0002
664 ACTIVITIES OF DAILY LIVING IMPAIRED 4 0.0002
665 CATARACT 12 0.0002
666 BLADDER DISORDER 2 0.0002
667 PULMONARY MASS 3 0.0002
668 AGEUSIA 5 0.0002
669 BRAIN INJURY 2 0.0002
670 PRODUCT PHYSICAL ISSUE 4 0.0002
671 OSTEOPENIA 3 0.0002
672 DRY THROAT 2 0.0002
673 VISION BLURRED 27 0.0002
674 MOTOR DYSFUNCTION 2 0.0002
675 HYPOPHAGIA 5 0.0002
676 TEMPERATURE INTOLERANCE 2 0.0002
677 BENIGN PROSTATIC HYPERPLASIA 1 0.0002
678 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
679 EYE DISCHARGE 2 0.0002
680 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 39 0.0002
681 PULMONARY HYPERTENSION 4 0.0002
682 NERVOUSNESS 10 0.0002
683 PRODUCT DOSE OMISSION ISSUE 56 0.0002
684 DYSURIA 7 0.0002
685 ERYTHEMA 39 0.0002
686 BACK PAIN 44 0.0002
687 INCONTINENCE 2 0.0002
688 DISEASE RECURRENCE 9 0.0002
689 INFLUENZA 21 0.0002
690 EYE SWELLING 7 0.0002
691 ABSCESS 3 0.0002
692 INJECTION SITE BRUISING 15 0.0002
693 DISTURBANCE IN ATTENTION 10 0.0002
694 OVERDOSE 40 0.0002
695 DECREASED ACTIVITY 2 0.0002
696 PRURITUS GENERALISED 4 0.0002
697 SKIN LACERATION 2 0.0002
698 ASTHENOPIA 1 0.0002
699 PHOTOSENSITIVITY REACTION 3 0.0002
700 DIVERTICULITIS 5 0.0002
701 LIP SWELLING 6 0.0002
702 FUNGAL INFECTION 6 0.0002
703 HAEMOPTYSIS 5 0.0002
704 BLOOD CALCIUM DECREASED 2 0.0002
705 CHROMATURIA 4 0.0002
706 COVID-19 31 0.0002
707 BLOOD PRESSURE INCREASED 27 0.0002
708 INTENTIONAL DOSE OMISSION 5 0.0002
709 CHOLECYSTECTOMY 2 0.0002
710 HYPERSOMNIA 5 0.0002
711 DYSSTASIA 5 0.0002
712 METASTASES TO LIVER 3 0.0002
713 DEPRESSED MOOD 9 0.0002
714 URINARY TRACT INFECTION 29 0.0002
715 LYMPHADENOPATHY 6 0.0002
716 HEAD DISCOMFORT 3 0.0002
717 DYSPHAGIA 16 0.0002
718 MACULAR DEGENERATION 2 0.0002
719 HYPERLIPIDAEMIA 2 0.0002
720 RASH ERYTHEMATOUS 8 0.0002
721 GOUT 3 0.0002
722 IRRITABILITY 10 0.0002
723 BLOOD POTASSIUM DECREASED 5 0.0002
724 TOOTHACHE 3 0.0002
725 SCHIZOPHRENIA 2 0.0002
726 END STAGE RENAL DISEASE 3 0.0002
727 INJECTION SITE PRURITUS 11 0.0002
728 INJECTION SITE PAIN 50 0.0002
729 GLOMERULAR FILTRATION RATE DECREASED 2 0.0002
730 CARDIOMEGALY 2 0.0002
731 CYST 2 0.0002
732 HEPATIC STEATOSIS 3 0.0002
733 TOOTH EXTRACTION 2 0.0002
734 CONSTIPATION 35 0.0002
735 PNEUMONIA ASPIRATION 4 0.0002
736 SECRETION DISCHARGE 2 0.0002
737 DYSPNOEA EXERTIONAL 6 0.0002
738 CELLULITIS 8 0.0002
739 BLOOD URINE PRESENT 3 0.0002
740 MUSCLE ATROPHY 2 0.0002
741 PULMONARY EMBOLISM 15 0.0002
742 INCREASED APPETITE 3 0.0002
743 GLAUCOMA 3 0.0002
744 ROTATOR CUFF SYNDROME 2 0.0002
745 INFUSION SITE PAIN 2 0.0002
746 ANOREXIA 2 0.0002
747 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
748 INJECTION SITE INDURATION 2 0.0002
749 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 8 0.0002
750 ABDOMINAL DISTENSION 16 0.0002
751 KIDNEY INFECTION 3 0.0002
752 SEDATION 4 0.0002
753 TINNITUS 7 0.0002
754 ANHEDONIA 4 0.0002
755 EYE DISORDER 5 0.0002
756 GASTRITIS 4 0.0002
757 IMMUNE SYSTEM DISORDER 2 0.0002
758 SARS-COV-2 TEST POSITIVE 2 0.0002
759 BLOOD PRESSURE ABNORMAL 3 0.0002
760 ADVERSE REACTION 2 0.0002
761 HAIR TEXTURE ABNORMAL 2 0.0001
762 MALIGNANT MELANOMA 2 0.0001
763 THROMBOSIS 12 0.0001
764 LOSS OF CONSCIOUSNESS 19 0.0001
765 DYSGEUSIA 11 0.0001
766 FLUSHING 15 0.0001
767 LIMB INJURY 4 0.0001
768 BODY TEMPERATURE INCREASED 3 0.0001
769 PRODUCT PREPARATION ERROR 3 0.0001
770 HOT FLUSH 11 0.0001
771 SKIN LESION 4 0.0001
772 HAEMATOCHEZIA 8 0.0001
773 NIGHTMARE 5 0.0001
774 AUTOIMMUNE HEPATITIS 1 0.0001
775 FEELING COLD 4 0.0001
776 HUNGER 2 0.0001
777 CARPAL TUNNEL SYNDROME 2 0.0001
778 BLOOD TEST ABNORMAL 2 0.0001
779 HYPOXIA 5 0.0001
780 PAIN IN JAW 4 0.0001
781 FLATULENCE 8 0.0001
782 RETCHING 3 0.0001
783 JOINT INJURY 3 0.0001
784 IMPAIRED WORK ABILITY 3 0.0001
785 SKIN CANCER 3 0.0001
786 BALANCE DISORDER 12 0.0001
787 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
788 PANIC ATTACK 5 0.0001
789 BONE PAIN 8 0.0001
790 THERAPY CESSATION 7 0.0001
791 FOETAL EXPOSURE DURING PREGNANCY 11 0.0001
792 FALL 45 0.0001
793 RENAL INJURY 4 0.0001
794 SPEECH DISORDER 7 0.0001
795 BONE LOSS 2 0.0001
796 HYPOAESTHESIA ORAL 2 0.0001
797 ECONOMIC PROBLEM 2 0.0001
798 DEVICE FAILURE 2 0.0001
799 SKIN IRRITATION 6 0.0001
800 INJECTION SITE REACTION 9 0.0001
801 EMOTIONAL DISORDER 4 0.0001
802 LYMPHOMA 2 0.0001
803 LIMB DISCOMFORT 4 0.0001
804 FEMUR FRACTURE 4 0.0001
805 LUNG INFECTION 2 0.0001
806 THERAPY PARTIAL RESPONDER 2 0.0001
807 BASAL CELL CARCINOMA 2 0.0001
808 BONE DENSITY DECREASED 4 0.0001
809 HEAD INJURY 4 0.0001
810 PNEUMOTHORAX 2 0.0001
811 PRODUCT PRESCRIBING ERROR 3 0.0001
812 ULCER 2 0.0001
813 CYSTITIS 4 0.0001
814 MOOD SWINGS 4 0.0001
815 ATRIAL FLUTTER 1 0.0001
816 BLOOD DISORDER 1 0.0001
817 LOCALISED INFECTION 3 0.0001
818 BLOOD POTASSIUM INCREASED 2 0.0001
819 PRODUCT DOSE OMISSION 8 0.0001
820 ABNORMAL FAECES 1 0.0001
821 CHOLELITHIASIS 4 0.0001
822 MULTIPLE FRACTURES 2 0.0001
823 EYE IRRITATION 7 0.0001
824 OSTEONECROSIS OF JAW 3 0.0001
825 INJECTION SITE ERYTHEMA 15 0.0001
826 DEHYDRATION 16 0.0001
827 SKIN DISORDER 4 0.0001
828 URINARY RETENTION 4 0.0001
829 DYSPHONIA 7 0.0001
830 CHILLS 14 0.0001
831 CANDIDA INFECTION 2 0.0001
832 DIABETES MELLITUS 9 0.0001
833 INJECTION SITE SWELLING 9 0.0001
834 ERECTILE DYSFUNCTION 3 0.0001
835 SCAR 2 0.0001
836 DRUG RESISTANCE 3 0.0001
837 GASTRIC DISORDER 4 0.0001
838 RASH GENERALISED 3 0.0001
839 LOCAL SWELLING 2 0.0001
840 COLD SWEAT 2 0.0001
841 ISCHAEMIC STROKE 2 0.0001
842 SKIN BURNING SENSATION 8 0.0001
843 PAIN OF SKIN 3 0.0001
844 PELVIC PAIN 2 0.0001
845 AGITATION 8 0.0001
846 SKIN DISCOLOURATION 5 0.0001
847 BLOOD GLUCOSE ABNORMAL 2 0.0001
848 RENAL DISORDER 5 0.0001
849 BACTERIAL INFECTION 2 0.0001
850 COGNITIVE DISORDER 5 0.0001
851 OXYGEN SATURATION DECREASED 6 0.0001
852 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
853 FRACTURE 2 0.0001
854 BLOOD PRESSURE DECREASED 7 0.0001
855 PROTEINURIA 2 0.0001
856 NEUROPATHY PERIPHERAL 10 0.0001
857 MULTIPLE SCLEROSIS 5 0.0001
858 HERPES ZOSTER 6 0.0001
859 LETHARGY 6 0.0001
860 DRUG PRESCRIBING ERROR 2 0.0001
861 AFFECT LABILITY 1 0.0001
862 PANCREATIC CARCINOMA 3 0.0001
863 NEEDLE ISSUE 3 0.0001
864 HAEMORRHOIDS 2 0.0001
865 TREMOR 17 0.0001
866 ABNORMAL BEHAVIOUR 4 0.0001
867 HAEMATOCRIT DECREASED 2 0.0001
868 SUICIDAL IDEATION 9 0.0001
869 BLINDNESS 4 0.0001
870 INJECTION SITE WARMTH 2 0.0001
871 TOOTH LOSS 2 0.0001
872 SWOLLEN TONGUE 3 0.0001
873 EATING DISORDER 2 0.0001
874 PLATELET COUNT DECREASED 10 0.0001
875 HIP FRACTURE 3 0.0001
876 INCORRECT PRODUCT ADMINISTRATION DURATION 2 0.0001
877 SWELLING FACE 6 0.0001
878 DEVICE DISLOCATION 4 0.0001
879 OSTEONECROSIS 3 0.0001
880 MELAENA 2 0.0001
881 EMOTIONAL DISTRESS 11 0.0001
882 RENAL FAILURE 12 0.0001
883 HYPOTENSION 18 0.0001
884 SEPSIS 10 0.0001
885 RASH PAPULAR 2 0.0001
886 TRANSIENT ISCHAEMIC ATTACK 3 0.0001
887 ANGER 3 0.0001
888 HEART RATE IRREGULAR 2 0.0001
889 MYALGIA 15 0.0001
890 PRODUCT AVAILABILITY ISSUE 2 0.0001
891 NEPHROLITHIASIS 4 0.0001
892 SHOCK 2 0.0001
893 MUSCLE TWITCHING 2 0.0001
894 NEOPLASM PROGRESSION 3 0.0001
895 HAEMORRHAGE 9 0.0001
896 ARRHYTHMIA 4 0.0001
897 CEREBRAL HAEMORRHAGE 3 0.0001
898 HEPATIC CANCER 2 0.0001
899 WHITE BLOOD CELL COUNT DECREASED 9 0.0001
900 CRYING 3 0.0001
901 PRESYNCOPE 2 0.0001
902 ABASIA 2 0.0001
903 INTESTINAL OBSTRUCTION 3 0.0001
904 HAEMATEMESIS 2 0.0001
905 HEPATITIS 2 0.0001
906 SEIZURE 9 0.0001
907 HAEMOGLOBIN DECREASED 8 0.0001
908 UNRESPONSIVE TO STIMULI 2 0.0001
909 SKIN ULCER 2 0.0001
910 DEAFNESS 2 0.0001
911 MUCOSAL INFLAMMATION 2 0.0001
912 BEDRIDDEN 1 0.0001
913 NEOPLASM MALIGNANT 5 0.0001
914 NEUTROPHIL COUNT DECREASED 3 0.0001
915 PNEUMONITIS 2 0.0001
916 MOOD ALTERED 2 0.0001
917 DRUG DOSE OMISSION 12 0.0001
918 ANAPHYLACTIC REACTION 4 0.0001
919 BURNING SENSATION 5 0.0001
920 HYPERHIDROSIS 9 0.0001
921 ANGINA PECTORIS 2 0.0001
922 PRODUCT SUBSTITUTION ISSUE 4 0.0001
923 LIVER FUNCTION TEST ABNORMAL 2 0.0001
924 PSYCHOTIC DISORDER 2 0.0001
925 UNEVALUABLE EVENT 5 0.0001
926 PLEURAL EFFUSION 4 0.0001
927 ANKLE FRACTURE 1 0.0001
928 CARDIAC DISORDER 6 0.0001
929 NERVOUS SYSTEM DISORDER 2 0.0001
930 HYPOTHYROIDISM 2 0.0001
931 INJECTION SITE HAEMORRHAGE 5 0.0001
932 MOVEMENT DISORDER 2 0.0001
933 CARDIAC FAILURE CONGESTIVE 5 0.0001
934 ATRIAL FIBRILLATION 6 0.0001
935 INFLUENZA LIKE ILLNESS 5 0.0001
936 VISUAL ACUITY REDUCED 2 0.0001
937 RENAL IMPAIRMENT 5 0.0001
938 CEREBROVASCULAR ACCIDENT 10 0.0001
939 ACUTE KIDNEY INJURY 9 0.0001
940 HAEMATURIA 2 0.0001
941 MULTIPLE SCLEROSIS RELAPSE 4 0.0001
942 ANAEMIA 11 0.0001
943 AMENORRHOEA 1 0.0001
944 HEART RATE DECREASED 2 0.0001
945 DEVICE MALFUNCTION 4 0.0001
946 DRUG INTERACTION 9 0.0001
947 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
948 THERAPY INTERRUPTED 4 0.0001
949 HYPERGLYCAEMIA 2 0.0001
950 BREAST CANCER 5 0.0001
951 HALLUCINATION 4 0.0001
952 ACNE 4 0.0001
953 CONVULSION 3 0.0001
954 DEATH 45 0.0001
955 MYOCARDIAL INFARCTION 9 0.0001
956 DRUG DOSE OMISSION BY DEVICE 4 0.0001
957 DISORIENTATION 2 0.0001
958 DEVICE BREAKAGE 2 0.0000
959 GASTROINTESTINAL HAEMORRHAGE 4 0.0000
960 RENAL FAILURE ACUTE 2 0.0000
961 HYPOACUSIS 2 0.0000
962 MENTAL DISORDER 2 0.0000
963 BLOOD CREATININE INCREASED 3 0.0000
964 PRODUCT STORAGE ERROR 4 0.0000
965 PULMONARY OEDEMA 2 0.0000
966 NO ADVERSE EVENT 8 0.0000
967 RENAL CANCER 2 0.0000
968 HYPOGLYCAEMIA 2 0.0000
969 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
970 AGGRESSION 2 0.0000
971 MALIGNANT NEOPLASM PROGRESSION 4 0.0000
972 ANAPHYLACTIC SHOCK 1 0.0000
973 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
974 PROSTATE CANCER 3 0.0000
975 NEUTROPENIA 5 0.0000
976 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
977 DRUG WITHDRAWAL SYNDROME 3 0.0000
978 ASCITES 1 0.0000
979 APHASIA 1 0.0000
980 DEVICE DIFFICULT TO USE 2 0.0000
981 THROMBOCYTOPENIA 3 0.0000
982 BLOOD GLUCOSE INCREASED 5 0.0000
983 CARDIAC FAILURE 2 0.0000
984 DRUG DEPENDENCE 4 0.0000
985 DEVICE ISSUE 2 0.0000
986 BLOOD GLUCOSE DECREASED 1 0.0000
987 SYNCOPE 2 0.0000
988 DISEASE PROGRESSION 2 0.0000
989 ALANINE AMINOTRANSFERASE INCREASED 1 0.0000